Reducing myoclonus after etomidate

Anesthesiology

Volumn 90, Issue 1, 1999, Pages 113-119

  Doenicke, Alfred W ^a   Roizen, Michael F ^a,b   Kugler, Johann ^a   Kroll, Heike ^a,c   Foss, Joseph ^a,b   Ostwald, Philipp ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Anesthesia; Epilepsy; Side effects

Indexed keywords

ETOMIDATE; INTRAVENOUS ANESTHETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HUMAN; MALE; MYOCLONUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; ANESTHETICS, INTRAVENOUS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ETOMIDATE; HUMANS; MALE; MYOCLONUS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0032615061     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199901000-00017     Document Type: Article

References (42)

1. Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Killian I, Bezecny H: Cerebral function under etomidate, a new non-barbiturate i.v. hypnotic. Anaesthesist 1973; 22:357-66
2. Kugler J, Doenicke A, Laub M: The EEG after etomidate. Anaesthesiol Resusc 1977; 106:31-48
3. Doenicke A, Kugler A, Vollmann N, Suttmann H, Taeger K: Etomidate with a new solubilizer. Experimental and clinical investigations on venous tolerance and bioavailability. Anaesthesist 1990; 39: 475-80
4. Doenicke A, Roizen MF, Hoernecke R, Ostwald P, Foss J: Haemolysis after etomidate: Comparison of propylene glycol and lipid formulations. Br J Anaesth 1997; 79:386-88
5. Kulka PJ, Bremer F, Schuttler J: Anaesthesia induction using etomidate in a lipid emulsion. Anaesthesist 1993; 42:205-9
6. Doenicke A, Roizen MF, Nebauer AE, Kugler A, Hoernecke R, Beger HH: A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol. Anesth Analg 1994; 79:933-9
7. Holdcroft A, Morgan M, Whitwam JG, Lumley J: Effect of dose and premedication on induction complications with etomidate. Br J Anaesth 1976; 48:199-205
8. Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD Jr, Link L: Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77:1008-11
9. Modica PA, Tempelhoff R, White PF: Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg 1990; 70:433-44
10. Gancher S, Laxer KD, Krieger W: Activation of epileptogenic activity by etomidate. ANESTHESIOLOGY 1984; 61:616-8
11. Laughlin TP, Newberg LA: Prolonged myoclonus after etomidate anesthesia. Anesth Analg 1985; 64:80-2
12. Ebrahim ZY, DeBoer GE, Luders H, Hahn JF, Lesser RP: Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg 1986; 65:1004-6
13. Kugler J: Untersuchungen mit dem Elektroenzephalographen, Elektroenzephalographie in Klinik und Praxis, 3th edition, Edited by Kugler J. Stuttgart, Germany, Thieme, 1981, pp 9-29
14. van Dijk B: Venous pain and involuntary muscular movements during and after administration of etomidate. A comparison of two different formulations. Anaesthesist 1978; 27:60-3
15. Horrigan RW, Moyers JR, Johnson BH, Eger EI, Margolis A, Goldsmith S: Etomidate vs. thiopental with and without fentanyl - A comparative study of awakening in man. ANESTHESIOLOGY 1980; 52: 362-4
16. Fragen RJ, Caldwell N: Comparison of a new formulation of etomidate with thiopental - Side effects and awakening times. ANESTHESIOLOGY 1979; 50:242-4
17. Korttila K, Tammisto T, Aromaa U: Comparison of etomidate in combination with fentanyl or diazepam, with thiopentone as an induction agent for general anaesthesia. Br J Anaesth 1979; 51:1151-7
18. Stockham RJ, Stanley TH, Pace NL, Gillmor S, Groen F, Hilkens P: Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intensive Care 1988; 16:171-6
19. Hallett M: Myoclonus: Relation to epilepsy. Epilepsia 1985; 26(Suppl 1):S67-S77
20. Lugaresi E, Coccagna G, Berti Ceroni G, Ambrosetto C: Restless legs syndrome and nocturnal myoclonus, The Abnormalities of Sleep in Man. Edited by Gastaut H, Lugaresi E, Berti Ceroni G, Coccagna G. Bologna, Aulo Gaggi Editore, 1968, pp 285-94
21. Loeb C: Les myoclonies hypniques dans les differents stades du sommeil chez les sujets normaux et chez differents groups des malades neurologiques, The Abnormalities of Sleep in Man. Edited by Gastaut H, Lugaresi E, Berti Ceroni G, Coccagna G. Bologna, Aulo Gaggi Editore, 1968, pp 311-7
22. Niedermeyer E, Fineyre F, Riley T, Bird B: Myoclonus and the electroencephalogram, a review. Clin Electroencephalogr 1979; 10: 75-95
23. Gastaut H: Dictionary of Epilepsy. Geneva, World Health Organization, 1973, p 42
24. Hoffmann P, Schockenhoff B: Etomidate as an anticonvulsive agent. Anaesthesist 1984; 33:142-4
25. Yeoman P, Hutchinson A, Byrne A, Smith J, Durham S: Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med 1989; 15:255-9
26. Payne TA, Bleck TP: Status epilepticus. Crit Care Clin 1997; 13:17-38
27. Anonymous: A glossary of terms most commonly used by clinical electrographers. Electroencephalogr Clin Neurophysiol 1974; 37: 538-48
28. Tempelhoff R, Modica PA, Bernardo KL, Edwards I: Fentanylinduced electrocorticographic seizures in patients with complex partial epilepsy. J Neurosurg 1992; 77:201-8
29. Garvey MJ, Tollefson GD: Occurrence of myoclonus in patients treated with cyclic antidepressants. Arch Gen Psychiatry 1987; 44: 269-72
30. Hufnagel A: Die physikalische und pharmakologische Aktivierung des epileptischen Fokus. Akt Neurol 1992; 19:28-9
31. Kugler J, Doenicke A: Ketamine - Anticonvulsive and proconvulsive properties. Anaesthesist 1994; 43:S2-S7
32. Casas M, Garcia RC, Alvarez E, Udina C, Queralto JM, Grau JM: Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine. Int Clin Psychopharmacol 1987; 2:333-6
33. Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-14
34. Yang J, Uchida I: Mechanisms of etomidate potentiation of GABAA receptor-gated currents in cultured postnatal hippocampal neurons. Neuroscience 1996; 73:69-78
35. Krasowski MD, Koltchine W, Rick CE, Ye Q, Finn SE, Harrison NL: Propofol and other intravenous anesthetics have sites of action on the γ-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998; 53:530-8
36. Whiting PJ, McKernan RM, Wafford KA: Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol 1995; 38:95-138
37. Hill-Venning C, Belelli D, Peters JA, Lambert JJ: Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor. Br J Pharmacol 1997; 120:749-56
38. Sanna E, Murgia A, Casula A, Biggio G: Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at gamma-aminobutyric acid type A receptors expressed in Xenopus laevis oocytes. Mol Pharmacol 1997; 51:484-90
39. Moody EJ, Knauer C, Granja R, Strakhova M, Skolnick P: Distinct loci mediate the direct and indirect actions of the anesthetic etomidate at GABA(A) receptors. J Neurochem 1997; 69:1310-3
40. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ: The interaction of the general anesthetic etomidate with the y-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci U S A 1997; 94:11031-6
41. Wisden W, Laurie DJ, Monyer H, Seeburg PH: The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12:1040-62
42. Davis DW, Mans AM, Biebuyck JF, Hawkins RA: Regional brain glucose utilization in rats during etomidate anesthesia. ANESTHESIOLOGY 1986; 64:751-7